SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is a Industrials company (Consulting Services) with a market capitalization of $629M. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), SBC Medical Group Holdings Incorporated had a Maz Rating of 4.62 out of 5 (A, Strong Buy), ranked against the other companies in its sector. Its strongest factor then was Financial Health (4.86), among the strongest in its sector; its weakest was Growth (2.45), below most of its sector. The other factors: Profitability 4.61 (among the strongest in its sector); Valuation 3.85 (more attractively valued than most of its sector); Momentum 2.86 (around the middle of its sector). The current rating is for members: log in to see it.
At $6.12, SBC Medical Group Holdings Incorporated trades at 12.2x trailing earnings, 3.3x sales and 2.1x book value, with an EV/EBITDA of 5.6. Over the last twelve months it generated about $191M of revenue and $52M of net income. It runs a gross margin of 72.0%, an operating margin of 39.9% and a net margin of 27.3%. It shows return on equity of 19.4%, return on invested capital of 13.5% and a free cash flow yield of 15.7%. On the balance sheet: a debt-to-equity ratio of 0.15 and a current ratio of 3.67. Over the past 52 weeks the share price ranged from $2.78 to $7.39, with a beta of 0.63.
SBC Medical Group Holdings Incorporated does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group's supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized procedures like laser skin toning, double fold eye surgery, rhinoplasty, hair transplants, laser hair removal, cosmetic dental work, tattoo removal, and advanced eye procedures like LASIK, among others. Established in 2000, SBC Medical Group Holdings Incorporated maintains its headquarters in Irvine, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, SBC Medical Group Holdings Incorporated (SBC) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 6.66% / 30% · (Cash+Inv) / Mkt Cap (36m) 47.8% / 30% · Interest income / Revenue 0.59% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 6.66% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 40.2% / 33% · Receivables / Mkt Cap (36m) 10.9% / 49% · Interest income / Revenue 0.59% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 6.66% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 40.2% / 33.33% · Receivables / Mkt Cap (24m) 10.9% / 33.33% · Interest income / Revenue 0.59% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 9.66% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 44.9% / 33.33% · Receivables / Avg Assets (4Q) 11.6% / 33.33% · Interest income / Revenue 0.59% / 5% | Fail |
| FTSE | Debt / Total Assets 7.91% / 33.33% · (Cash+ST Inv) / Total Assets 47.7% / 33.33% · (Cash+Recv) / Total Assets 60.6% / 33.33% · Interest income / Revenue 0.59% / 5% | Fail |
No. As of September 2026, SBC Medical Group Holdings Incorporated (SBC) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. SBC Medical Group Holdings Incorporated is over the AAOIFI limit on (Cash+Inv) / Mkt Cap (36m).
About 0.59% of each dividend: SBC Medical Group Holdings Incorporated's interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.